ID: ALA4084655

Max Phase: Preclinical

Molecular Formula: C12H14N2O

Molecular Weight: 202.26

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)c1ccc2cc(C(N)=O)[nH]c2c1

Standard InChI:  InChI=1S/C12H14N2O/c1-7(2)8-3-4-9-6-11(12(13)15)14-10(9)5-8/h3-7,14H,1-2H3,(H2,13,15)

Standard InChI Key:  PNTHLTUANCYMTH-UHFFFAOYSA-N

Associated Targets(Human)

EIF4A3 Tchem Eukaryotic initiation factor 4A-III (131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 202.26Molecular Weight (Monoisotopic): 202.1106AlogP: 2.39#Rotatable Bonds: 2
Polar Surface Area: 58.88Molecular Species: NEUTRALHBA: 1HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.09CX LogD: 2.09
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.77Np Likeness Score: -0.68

References

1. Ito M, Iwatani M, Kamada Y, Sogabe S, Nakao S, Tanaka T, Kawamoto T, Aparicio S, Nakanishi A, Imaeda Y..  (2017)  Discovery of selective ATP-competitive eIF4A3 inhibitors.,  25  (7): [PMID:28283335] [10.1016/j.bmc.2017.02.035]

Source